Abstract #0188

Predicting TP53 mutational status of breast cancers on clinical DCE MRI using directional-gradient based radiogenomic descriptors

Nathaniel Braman¹, Prateek Prasanna¹, Donna Plecha², Hannah Gilmore², Lyndsay Harris², Kristy Miskimen¹, Tao Wan³, Vinay Varadan¹, and Anant Madabhushi¹

¹Case Western Reserve University, Cleveland, OH, United States, ²University Hospitals, Cleveland, OH, United States, ³Beihang University, Beijing, China, People's Republic of

In this work, we report preliminary success in the prediction of TP53 mutational status in breast cancer from DCE-MRI using a computer-extracted radiogenomic descriptor of multi-scale disorder, Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe). A set of 8 distinguishing CoLlAGe features yielded accuracy of 78% in predicting TP53 mutational status and outperformed standard DCE-MRI pharmacokinetic parameters in an unsupervised hierarchical clustering. A non-invasive means of discerning TP53 mutational status may allow clinicians to more easily determine prognosis, assess treatment response, and inform treatment strategy.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.